Source 1primary paper2024MED
Toolkit/smart bioelectronic devices
smart bioelectronic devices
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
In addition, we introduce the development of cell encapsulation and delivery methods and smart bioelectronic devices for the in vivo application of optogenetics-based cell therapy in diabetes.
Usefulness & Problems
Why this is useful
Smart bioelectronic devices are presented as part of the in vivo application framework for optogenetics-based cell therapy in diabetes.; in vivo application of optogenetics-based cell therapy in diabetes
Source:
Smart bioelectronic devices are presented as part of the in vivo application framework for optogenetics-based cell therapy in diabetes.
Source:
in vivo application of optogenetics-based cell therapy in diabetes
Problem solved
They help address how optogenetic cell therapies can be applied in vivo.; supports in vivo implementation of optogenetics-based cell therapy
Source:
They help address how optogenetic cell therapies can be applied in vivo.
Source:
supports in vivo implementation of optogenetics-based cell therapy
Problem links
supports in vivo implementation of optogenetics-based cell therapy
LiteratureThey help address how optogenetic cell therapies can be applied in vivo.
Source:
They help address how optogenetic cell therapies can be applied in vivo.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
Translation ControlTechniques
No technique tags yet.
Target processes
translationInput: Light
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: externally suppliedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: delivery
The abstract supports that these devices are used together with optogenetics-based cell therapy and related delivery methods.; must be integrated with optogenetics-based cell therapy for in vivo use
The abstract does not show that smart bioelectronic devices alone solve the broader clinical translation challenges discussed by the review.; clinical translational challenges remain
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Cell encapsulation and delivery methods and smart bioelectronic devices are being developed for the in vivo application of optogenetics-based cell therapy in diabetes.
Optogenetics-based cell therapy for diabetes still faces challenges in clinical translational study.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug smart-bioelectronic-devices
In addition, we introduce the development of cell encapsulation and delivery methods and smart bioelectronic devices for the in vivo application of optogenetics-based cell therapy in diabetes.
Source:
delivery enablersupports
Cell encapsulation and delivery methods and smart bioelectronic devices are being developed for the in vivo application of optogenetics-based cell therapy in diabetes.
Source:
limitationsupports
Optogenetics-based cell therapy for diabetes still faces challenges in clinical translational study.
Source:
Comparisons
Source-stated alternatives
The abstract mentions cell encapsulation and delivery methods as parallel enabling approaches for in vivo application.
Source:
The abstract mentions cell encapsulation and delivery methods as parallel enabling approaches for in vivo application.
Source-backed strengths
positioned for in vivo application
Source:
positioned for in vivo application
Compared with Adeno-associated virus
smart bioelectronic devices and Adeno-associated virus address a similar problem space because they share translation.
Shared frame: same top-level item type; shared target processes: translation; shared mechanisms: translation_control; same primary input modality: light
Strengths here: may avoid an exogenous cofactor requirement.
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Compared with Deep Brain Stimulation
smart bioelectronic devices and Deep Brain Stimulation address a similar problem space because they share translation.
Shared frame: same top-level item type; shared target processes: translation; shared mechanisms: translation_control; same primary input modality: light
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Compared with microfabricated LED cochlear implant
smart bioelectronic devices and microfabricated LED cochlear implant address a similar problem space because they share translation.
Shared frame: same top-level item type; shared target processes: translation; shared mechanisms: translation_control; same primary input modality: light
Ranked Citations
- 1.